Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP)

AIMS: The aim of this study is to extend the analysis of the Lung Cancer Biomarker Testing Registry (LungPath), by analysing the techniques used in the determination of epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1) and programmed death ligand-1 (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-López, Javier, Rojo, Federico, Martínez-Pozo, Antonio, Hernández-Iglesias, Teresa, Carcedo, David, de Alda, Lucía Ruiz, García, J Francisco, Salas, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176377/
https://www.ncbi.nlm.nih.gov/pubmed/34903610
http://dx.doi.org/10.1136/jclinpath-2021-208034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176377/
https://www.ncbi.nlm.nih.gov/pubmed/34903610
http://dx.doi.org/10.1136/jclinpath-2021-208034

Ejemplares similares